Home › Free Stock Grades › INSM
Insmed Incorporated (INSM) Stock Grade
INSM · Healthcare
A+
Market Cap
$26.8B
P/E Ratio
—
Revenue Growth (YoY)
+66.7%
Net Margin
-210.5%
Return on Equity
—
Dividend Yield
None
About Insmed Incorporated's fundamentals
Insmed is a biotechnology company with a market capitalization of $26.8 billion that is experiencing strong revenue growth of 66.7% year-over-year. However, the company is currently unprofitable, reporting a net loss in its latest annual statement and operating at a net margin of -210.5%, meaning expenses significantly exceed revenues. The company does not pay a dividend, which is typical for growth-stage biotech firms reinvesting capital into research and development. This profile reflects a company prioritizing revenue expansion and product development over current profitability.